1
|
Chudzinski R, Levron A, Agard E, Douma I, Billant J, Dot C. Comparison of corneal topography maps obtained using the IOLMaster 700 ® and the Anterion ® in candidates for toric IOL implantation. Eye (Lond) 2024:10.1038/s41433-024-03094-1. [PMID: 38653750 DOI: 10.1038/s41433-024-03094-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2023] [Revised: 03/06/2024] [Accepted: 04/12/2024] [Indexed: 04/25/2024] Open
Abstract
OBJECTIVES To compare central corneal topography (CT) obtained using the IOLMaster 700® biometer to corneal topography obtained using a Swept-Source OCT-based predicated topographer (PT), in candidates for toric intraocular lens (IOL) implantation. METHODS A retrospective comparative study was conducted in consecutive patients undergoing a routine cataract surgery assessment with significant astigmatism on keratometry. Each patient was examined using both the IOLMaster 700® (Carl Zeiss Meditec, Jena, Germany) and the Anterion® (Heidelberg Engineering, Heidelberg, Germany) for routine preoperative measurements. The corneal axial anterior power map obtained with each device was then anonymized and analysed independently by two ophthalmologists using a reading grid. The reading grid assessed the usual parameters describing astigmatism and evaluated if a toric IOL was indicated or a second topography examination was needed to confirm the indication. RESULTS In total, 169 eyes of 120 patients were included. The inter-examination agreement for the astigmatism description ranged from 56 to 85% depending on the reader and parameter. The decision to implant a toric IOL based on the axial map was the same in 59-60% of cases depending on the examiner. A second examination was needed in 18-25% and 8-14% of cases after CT and PT, respectively. The IOLMaster 700® central anterior axial map allowed toric IOL implantation in 58-70% of cases with no need for second corneal examination. CONCLUSION The agreement between the anterior axial maps obtained using both devices was good. However, in about a quarter of the cases, dedicated topography had to be performed to confirm the surgical indication.
Collapse
Affiliation(s)
- Roman Chudzinski
- Department of Ophthalmology, Edouard Herriot University Hospital, Hospices Civils de Lyon, France
| | | | | | | | - Jérémy Billant
- Department of Ophthalmology, Edouard Herriot University Hospital, Hospices Civils de Lyon, France
- Desgenettes Military Hospital, Lyon, France
| | - Corinne Dot
- Department of Ophthalmology, Edouard Herriot University Hospital, Hospices Civils de Lyon, France.
- Desgenettes Military Hospital, Lyon, France.
- French Military Health Service Academy of Val de Grâce, Paris, France.
| |
Collapse
|
2
|
Bouvarel H, Agard E, Billant J, Levron A, Chudzinski R, Plas H, Bernier R, Sejournet L, Chaperon M, Dot C. Correction: Long-term real-life outcomes of the Clareon® hydrophobic intraocular lens: the Clarte study in 191 eyes : 3-years real-life outcomes of the Clareon® intraocular lens. BMC Ophthalmol 2024; 24:178. [PMID: 38641586 PMCID: PMC11027327 DOI: 10.1186/s12886-024-03451-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/21/2024] Open
Affiliation(s)
- Hugo Bouvarel
- Department of Ophthalmology, Hospices Civils de Lyon, E. Herriot University Hospital, Lyon, France.
| | - Emilie Agard
- Department of Ophthalmology, Desgenettes Military Hospital, Lyon, France
| | - Jérémy Billant
- Department of Ophthalmology, Hospices Civils de Lyon, E. Herriot University Hospital, Lyon, France
- Department of Ophthalmology, Desgenettes Military Hospital, Lyon, France
| | - Antoine Levron
- Department of Ophthalmology, Hospices Civils de Lyon, E. Herriot University Hospital, Lyon, France
| | - Roman Chudzinski
- Department of Ophthalmology, Hospices Civils de Lyon, E. Herriot University Hospital, Lyon, France
| | - Hélène Plas
- Department of Ophthalmology, Hospices Civils de Lyon, E. Herriot University Hospital, Lyon, France
| | - Raphaël Bernier
- Department of Ophthalmology, Hospices Civils de Lyon, E. Herriot University Hospital, Lyon, France
| | - Lucas Sejournet
- Department of Ophthalmology, Hospices Civils de Lyon, E. Herriot University Hospital, Lyon, France
| | - Mayeul Chaperon
- Department of Ophthalmology, Hospices Civils de Lyon, E. Herriot University Hospital, Lyon, France
| | - Corinne Dot
- Department of Ophthalmology, Hospices Civils de Lyon, E. Herriot University Hospital, Lyon, France
- Department of Ophthalmology, Desgenettes Military Hospital, Lyon, France
- French Military Medical Academy, Val-de-Grâce, Paris, France
| |
Collapse
|
3
|
Bouvarel H, Agard E, Billant J, Levron A, Chudzinski R, Plas H, Bernier R, Sejournet L, Chaperon M, Dot C. Long-term real-life outcomes of the Clareon® hydrophobic intraocular lens: the Clarte study in 191 eyes : 3-years real-life outcomes of the Clareon® intraocular lens. BMC Ophthalmol 2024; 24:133. [PMID: 38532367 PMCID: PMC10964544 DOI: 10.1186/s12886-024-03393-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2023] [Accepted: 03/13/2024] [Indexed: 03/28/2024] Open
Abstract
BACKGROUND To describe and analyze the real-life refractive, functional and safety outcomes of the Clareon® intraocular lens (IOL) after 3 years. METHODS Data was collected retrospectively for observational purposes between July 2017 and December 2019 in the ophthalmology department of Desgenettes military hospital in Lyon, France. Eyes that underwent cataract surgery with Claeron® implantation were consecutively included. Patients with a systemic or ocular condition that could affect the visual outcome were excluded. Postoperative corrected (CDVA) and uncorrected (UDVA) distance visual acuities as well as capsule and IOL transparency were assessed at 1 month and 3 years. RESULTS A total of 326 eyes were analyzed at one month and 191 eyes were reassessed at the 3-year follow-up visit. At 3 years, the mean CDVA was 0.003 LogMAR (95% confidence interval [CI]: -0.003 to -0.01) and the mean UDVA was 0.075 (95% CI: 0.054 to 0.095). Three quarters of the patients had an UDVA ≥ 0.097 logMAR (20/25 Snellen equivalent) and 50% had an UDVA ≥ 0 (20/20). The absence of glistening was reported in 95.3% of cases and 4.7% [9] of patients experienced a clinically significant posterior capsular opacification (PCO) for which Nd:YAG treatment was required. CONCLUSIONS This real-life study reports high-performance and stable long-term refractive outcomes of the Clareon® IOL with good safety in terms of PCO and glistening.
Collapse
Affiliation(s)
- Hugo Bouvarel
- Department of Ophthalmology, Hospices Civils de Lyon, E. Herriot University Hospital, Lyon, France.
| | - Emilie Agard
- Department of Ophthalmology, Desgenettes Military Hospital, Lyon, France
| | - Jérémy Billant
- Department of Ophthalmology, Hospices Civils de Lyon, E. Herriot University Hospital, Lyon, France
- Department of Ophthalmology, Desgenettes Military Hospital, Lyon, France
| | - Antoine Levron
- Department of Ophthalmology, Hospices Civils de Lyon, E. Herriot University Hospital, Lyon, France
| | - Roman Chudzinski
- Department of Ophthalmology, Hospices Civils de Lyon, E. Herriot University Hospital, Lyon, France
| | - Hélène Plas
- Department of Ophthalmology, Hospices Civils de Lyon, E. Herriot University Hospital, Lyon, France
| | - Raphaël Bernier
- Department of Ophthalmology, Hospices Civils de Lyon, E. Herriot University Hospital, Lyon, France
| | - Lucas Sejournet
- Department of Ophthalmology, Hospices Civils de Lyon, E. Herriot University Hospital, Lyon, France
| | - Mayeul Chaperon
- Department of Ophthalmology, Hospices Civils de Lyon, E. Herriot University Hospital, Lyon, France
| | - Corinne Dot
- Department of Ophthalmology, Hospices Civils de Lyon, E. Herriot University Hospital, Lyon, France
- Department of Ophthalmology, Desgenettes Military Hospital, Lyon, France
- French Military Medical Academy, Val-de-Grâce, Paris, France
| |
Collapse
|
4
|
Leroux P, Agard E, Billant J, Levron A, Bouvarel H, Badri Y, Douma I, Pradat P, Dot C. Long Intervals between Intravitreal Injections Using a Treat-and-Extend Protocol in a Real-Life Context in AMD: The LIRE Study. Ophthalmologica 2023; 247:44-57. [PMID: 38104545 PMCID: PMC10836925 DOI: 10.1159/000535806] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2023] [Accepted: 12/11/2023] [Indexed: 12/19/2023]
Abstract
INTRODUCTION The aim of the study was to assess the outcome of long treat-and-extend (TE) anti-VEGF intravitreal injection (IVI) intervals (≥every 12 weeks [Q12W]) in neovascular age-related macular degeneration (nAMD). The aims of this retrospective study were to determine the proportion of nAMD eyes treated ≥ Q12W, to analyze their longitudinal, functional, and anatomical outcomes, and to compare functional and anatomical outcomes between eyes that rapidly versus slowly reached a Q12W regimen and between eyes directly treated with versus initiating lately the TE regimen. METHODS All patients receiving IVIs for nAMD were screened. The longitudinal, functional, and anatomical characteristics of Q12W-treated eyes were reported at different timepoints. RESULTS Ninety-one eyes were included (38% of our total nAMD cohort). The mean TE regimen time to reach a Q12W interval was 20.1 ± 16.2 months. During this time, a mean number of 12.1 ± 9.3 IVIs were needed. The mean best-corrected visual acuity was 68 letters at the time of diagnosis and was maintained (p > 0.05). Eyes that rapidly reached a Q12W interval had a shorter follow-up before TE regimen initiation (p = 0.04) and received fewer IVIs (p = 0.02) than eyes that slowly reached a Q12W interval. Eyes directly treated with the TE regimen reached a Q12W interval more rapidly than eyes with late TE initiation. The neovascularization subtype was not a predictor of outcome in TE-treated eyes. CONCLUSION ≥Q12W eyes represent an important part of the nAMD population in our real-life study. No baseline anatomical characteristics were associated with the outcome under a TE regimen, although early TE regimen initiation allowed extending more rapidly the IVI interval.
Collapse
Affiliation(s)
- Pierre Leroux
- Department of Ophthalmology, Edouard Herriot University Hospital, Hospices Civils de Lyon, Lyon, France,
- University Claude Bernard Lyon 1, Villeurbanne, France,
| | - Emilie Agard
- Department of Ophthalmology, Desgenettes Military Hospital, Lyon, France
| | - Jérémy Billant
- Department of Ophthalmology, Edouard Herriot University Hospital, Hospices Civils de Lyon, Lyon, France
- Department of Ophthalmology, Desgenettes Military Hospital, Lyon, France
| | - Antoine Levron
- Department of Ophthalmology, Desgenettes Military Hospital, Lyon, France
| | - Hugo Bouvarel
- Department of Ophthalmology, Edouard Herriot University Hospital, Hospices Civils de Lyon, Lyon, France
- University Claude Bernard Lyon 1, Villeurbanne, France
| | - Yannis Badri
- Department of Ophthalmology, Edouard Herriot University Hospital, Hospices Civils de Lyon, Lyon, France
- University Claude Bernard Lyon 1, Villeurbanne, France
| | - Ikrame Douma
- Department of Ophthalmology, Desgenettes Military Hospital, Lyon, France
| | - Pierre Pradat
- Centre for Clinical Research, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France
| | - Corinne Dot
- Department of Ophthalmology, Edouard Herriot University Hospital, Hospices Civils de Lyon, Lyon, France
- Department of Ophthalmology, Desgenettes Military Hospital, Lyon, France
- French Military Academy of Val-de-Grâce, Paris, France
| |
Collapse
|
5
|
Billant J, Douma I, Agard E, Levron A, Bouvarel H, Leroux P, Badri Y, Dot C. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases]. J Fr Ophtalmol 2023:S0181-5512(23)00410-2. [PMID: 37758545 DOI: 10.1016/j.jfo.2023.03.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2023] [Revised: 03/27/2023] [Accepted: 03/29/2023] [Indexed: 09/29/2023]
Abstract
INTRODUCTION Steroid-induced ocular hypertension (OHT) occurs in approximately one third of cases after dexamethasone implant (DEXi) injection. Among these, more than one fifth occur after the third DEXi intravitreal injection (IVI). Our goal was to analyze the clinical profiles of these late responders. MATERIAL AND METHODS A real-life, retrospective, observational study was conducted to assess demographic characteristics and intraocular pressure (IOP) responses in late responders (IOP ≥ 21mmHg, n DEXi ≥ 4). The following parameters were analyzed: IOP 2 months after IVI and number of glaucoma medications needed. The IOP response compared to baseline was defined as low (< +6mmHg), moderate (≤ +15mmHg) or high (> 15mmHg). RESULTS Late steroid-induced OHT occurred in 20.8% of cases. Twenty eyes (18 patients) were included. The mean duration of follow-up was 3.8±1.9 years. They received a mean number of 9.5±4.2 IVI. The first OHT peak, measured at 25.3±3.2mmHg (21-31), occurred after 6.8±2.3 IVI. Approximately 65% of OHT spikes occurred between the fourth and sixth IVI; 35% occurred later. At maximum, 1.7±1.0 glaucoma medications and 0.75±0.79 SLT procedures were required to control the OHT, with no filtering surgery required. The ratio of "low," "moderate," and "high" responders was 5%, 85% and 10% respectively. CONCLUSION Late steroid-induced OHT occurs after at least 3 DEXi in one fifth of multi-injected patients, requiring long-term IOP monitoring. This case series identifies mostly moderate responder profiles, whose IOP rise often remains well-controlled with medical management or laser treatment (SLT).
Collapse
Affiliation(s)
- J Billant
- Service d'ophtalmologie, hôpital d'instruction des Armées Desgenettes, Lyon, France.
| | - I Douma
- Service d'ophtalmologie, hôpital d'instruction des Armées Desgenettes, Lyon, France
| | - E Agard
- Service d'ophtalmologie, hôpital d'instruction des Armées Desgenettes, Lyon, France
| | - A Levron
- Service d'ophtalmologie, hôpital d'instruction des Armées Desgenettes, Lyon, France
| | - H Bouvarel
- Service d'ophtalmologie, hôpital d'instruction des Armées Desgenettes, Lyon, France
| | - P Leroux
- Service d'ophtalmologie, hôpital d'instruction des Armées Desgenettes, Lyon, France
| | - Y Badri
- Service d'ophtalmologie, hôpital d'instruction des Armées Desgenettes, Lyon, France
| | - C Dot
- Service d'ophtalmologie, hôpital d'instruction des Armées Desgenettes, Lyon, France; École du Val-de-Grâce, Paris, France; Service d'ophtalmologie, hôpital Édouard-Herriot, hospices civils de Lyon, Lyon, France
| |
Collapse
|
6
|
Plas H, Agard É, Chehab HE, Levron A, Bouvarel H, Chirpaz N, Rochet E, Billant J, Dot C. Maculopathie toxique induite par le tamoxifène à faible dose cumulée : intérêt de l’imagerie multimodale. J Fr Ophtalmol 2022; 45:e450-e454. [DOI: 10.1016/j.jfo.2022.03.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2021] [Revised: 03/06/2022] [Accepted: 03/29/2022] [Indexed: 10/16/2022]
|
7
|
Bouvarel H, Hamard P, Agard E, Billant J, El Chehab H, Dot C. Macular edema in Cogan-Reese syndrome. Am J Ophthalmol Case Rep 2022; 25:101318. [PMID: 35128161 PMCID: PMC8810354 DOI: 10.1016/j.ajoc.2022.101318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2020] [Revised: 06/19/2021] [Accepted: 01/20/2022] [Indexed: 11/10/2022] Open
Abstract
PURPOSE Iridocorneo-endothelial (ICE) syndrome is known as a rare spectrum causing glaucoma, corneal and iris damages. Retinal complications are uncommon. OBSERVATIONS We report the case of a middle-aged woman suffering from a Cogan-Reese Syndrome (CRS) with refractory ocular hypertension (OHT) who presented a cystoid macular edema (CME) during follow up. CONCLUSIONS AND IMPORTANCE We suspect the CME to be inflammatory linked to the pathophysiological hypotheses of the CRS. The CME was successfully treated with topical nonsteroidal anti-inflammatory drugs (NSAID). No consensus is available on its duration. A recurrence happened when treatment was stopped, its reintroduction was successful.
Collapse
Affiliation(s)
- Hugo Bouvarel
- Hôpital d'Instruction des Armées Desgenettes, 108 Boulevard Pinel, 69003, Lyon, France
| | - Pascale Hamard
- Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, 28 Rue de Charenton, 75012, Paris, France
| | - Emilie Agard
- Hôpital d'Instruction des Armées Desgenettes, 108 Boulevard Pinel, 69003, Lyon, France
| | - Jérémy Billant
- Hôpital d'Instruction des Armées Desgenettes, 108 Boulevard Pinel, 69003, Lyon, France
| | - Hussam El Chehab
- Hôpital d'Instruction des Armées Desgenettes, 108 Boulevard Pinel, 69003, Lyon, France
| | - Corinne Dot
- Hôpital d'Instruction des Armées Desgenettes, 108 Boulevard Pinel, 69003, Lyon, France
| |
Collapse
|
8
|
Rochet E, Levron A, Agard E, Chehab HE, Plas H, Bouvarel H, Chirpaz N, Billant J, Dot C. Should Artificial Tears Be Used During the Preoperative Assessment of Toric IOLs Before Age-Related Cataract Surgery? The TORIDE Study. J Refract Surg 2021; 37:759-766. [PMID: 34756138 DOI: 10.3928/1081597x-20210826-01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
PURPOSE To assess the impact of the use of artificial tears during the preoperative work-up performed before age-related cataract surgery, when a toric intraocular lens (IOL) was indicated. METHODS This was a monocentric prospective study assessing 73 eyes of 51 patients, included consecutively after a preoperative work-up performed without artificial tears (no artificial tears group), when a toric IOL was indicated. Each included patient underwent a second series of examinations: biometry using the IOLMaster 700 (Carl Zeiss Meditec AG) and topography using the OPD-Scan II (Nidek), 1 minute after artificial tears instillation (artificial tears group; hyaluronate de sodium 0.15%, threalose 3% [Théalose; Théa]). Changes in anterior corneal astigmatism and subsequent changes in toric IOL calculation were analyzed. The error in predicted residual astigmatism was calculated. RESULTS Anterior corneal astigmatism and total corneal astigmatism measured with the IOLMaster 700 were significantly modified when artificial tears were instilled before the examinations (1.51 ± 0.57 diopters [D], range: 0.75 to -3.55 vs 1.42 ± 0.63 D, range: 0.42 to 3.35 D; P = .043 and 1.59 ± 0.54 D, range: 0.87 to 3.48 vs 1.51 ± 0.59 D, range: 0.56 to 3.27 D, P = .038, respectively). This modification led to a change in IOL cylinder calculation in 43.8% of cases and to a change in implantation axis greater than 10° in 17.7% of cases. These changes were significantly greater in patients with a breakup time (BUT) less than 5 seconds (57.5% and 27.8%, with P = .009 and .029, respectively). In the subgroup of patients with a BUT of less than 5 seconds, the mean absolute error in predicted astigmatism was significantly lower after artificial tears instillation (0.48 ± 0.50 D, range: 0.00 to 2.79 vs 0.37 ± 0.25 D, range: 0.00 to 1.10 D, P = .048). CONCLUSIONS Dry eye significantly impacted toric IOL calculations and should be taken into account during the preoperative assessments. Using artificial tears reduced the number of refractive errors. [J Refract Surg. 2021;37(11):759-766.].
Collapse
|